MCEWEN INC (MUX) Stock Fundamental Analysis

NYSE:MUX • US58039P3055

24.11 USD
-1.6 (-6.22%)
At close: Feb 17, 2026
24.3 USD
+0.19 (+0.79%)
After Hours: 2/17/2026, 7:33:40 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

MUX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 157 industry peers in the Metals & Mining industry. MUX has a bad profitability rating. Also its financial health evaluation is rather negative. MUX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • MUX had negative earnings in the past year.
  • MUX had a positive operating cash flow in the past year.
  • MUX had negative earnings in 4 of the past 5 years.
  • In the past 5 years MUX reported 4 times negative operating cash flow.
MUX Yearly Net Income VS EBIT VS OCF VS FCFMUX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • MUX has a Return On Assets (-1.59%) which is in line with its industry peers.
  • The Return On Equity of MUX (-2.44%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.59%
ROE -2.44%
ROIC N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
MUX Yearly ROA, ROE, ROICMUX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

  • With a Gross Margin value of 18.34%, MUX perfoms like the industry average, outperforming 55.41% of the companies in the same industry.
  • MUX's Gross Margin has improved in the last couple of years.
  • MUX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
MUX Yearly Profit, Operating, Gross MarginsMUX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MUX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MUX has been increased compared to 5 years ago.
  • The debt/assets ratio for MUX has been reduced compared to a year ago.
MUX Yearly Shares OutstandingMUX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MUX Yearly Total Debt VS Total AssetsMUX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • MUX has an Altman-Z score of 1.33. This is a bad value and indicates that MUX is not financially healthy and even has some risk of bankruptcy.
  • MUX has a Altman-Z score of 1.33. This is in the lower half of the industry: MUX underperforms 78.98% of its industry peers.
  • MUX has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • MUX has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACCN/A
WACC10.4%
MUX Yearly LT Debt VS Equity VS FCFMUX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • MUX has a Current Ratio of 2.10. This indicates that MUX is financially healthy and has no problem in meeting its short term obligations.
  • MUX has a Current ratio (2.10) which is comparable to the rest of the industry.
  • MUX has a Quick Ratio of 1.58. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
  • MUX has a Quick ratio (1.58) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 1.58
MUX Yearly Current Assets VS Current LiabilitesMUX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.80% over the past year.
  • MUX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.62%.
  • MUX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.32% yearly.
EPS 1Y (TTM)61.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)-16.62%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-3.28%

3.2 Future

  • MUX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 105.38% yearly.
  • MUX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.50% yearly.
EPS Next Y104.89%
EPS Next 2Y114.12%
EPS Next 3Y105.38%
EPS Next 5YN/A
Revenue Next Year-11.27%
Revenue Next 2Y13.43%
Revenue Next 3Y9.5%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MUX Yearly Revenue VS EstimatesMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MUX Yearly EPS VS EstimatesMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 15.04, the valuation of MUX can be described as correct.
  • 69.43% of the companies in the same industry are more expensive than MUX, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, MUX is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.04
MUX Price Earnings VS Forward Price EarningsMUX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MUX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 131.59
MUX Per share dataMUX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • MUX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MUX's earnings are expected to grow with 105.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.12%
EPS Next 3Y105.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MUX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MCEWEN INC

NYSE:MUX (2/17/2026, 7:33:40 PM)

After market: 24.3 +0.19 (+0.79%)

24.11

-1.6 (-6.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-05
Earnings (Next)03-12
Inst Owners45.87%
Inst Owner Change3.08%
Ins Owners0.6%
Ins Owner Change0.8%
Market Cap1.43B
Revenue(TTM)166.45M
Net Income(TTM)-11.92M
Analysts80
Price Target27.85 (15.51%)
Short Float %20.75%
Short Ratio7.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)193.94%
Min EPS beat(2)-106.19%
Max EPS beat(2)494.06%
EPS beat(4)1
Avg EPS beat(4)46.88%
Min EPS beat(4)-197.03%
Max EPS beat(4)494.06%
EPS beat(8)3
Avg EPS beat(8)8.28%
EPS beat(12)5
Avg EPS beat(12)-40.66%
EPS beat(16)6
Avg EPS beat(16)-62.37%
Revenue beat(2)0
Avg Revenue beat(2)-13.91%
Min Revenue beat(2)-22.09%
Max Revenue beat(2)-5.74%
Revenue beat(4)1
Avg Revenue beat(4)-8.56%
Min Revenue beat(4)-22.09%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-1.07%
Revenue beat(12)6
Avg Revenue beat(12)-3.06%
Revenue beat(16)6
Avg Revenue beat(16)-5.73%
PT rev (1m)20.8%
PT rev (3m)13.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.38%
EPS NY rev (1m)1000.9%
EPS NY rev (3m)-92.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.03%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-8.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.04
P/S 8.61
P/FCF N/A
P/OCF 562.13
P/B 2.93
P/tB 2.93
EV/EBITDA 131.59
EPS(TTM)-0.34
EYN/A
EPS(NY)1.6
Fwd EY6.65%
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)0.04
OCFY0.18%
SpS2.8
BVpS8.22
TBVpS8.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.59%
ROE -2.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.34%
FCFM N/A
ROA(3y)-4.5%
ROA(5y)-10.95%
ROE(3y)-7.65%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y18.18%
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 10.66
Cap/Depr 181.37%
Cap/Sales 29.99%
Interest Coverage N/A
Cash Conversion 21.58%
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 1.58
Altman-Z 1.33
F-Score4
WACC10.4%
ROIC/WACCN/A
Cap/Depr(3y)153.99%
Cap/Depr(5y)131.29%
Cap/Sales(3y)27.62%
Cap/Sales(5y)24.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y104.89%
EPS Next 2Y114.12%
EPS Next 3Y105.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.62%
Revenue growth 3Y8.53%
Revenue growth 5Y8.32%
Sales Q2Q%-3.28%
Revenue Next Year-11.27%
Revenue Next 2Y13.43%
Revenue Next 3Y9.5%
Revenue Next 5YN/A
EBIT growth 1Y-1953.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.49%
EBIT Next 3Y118.78%
EBIT Next 5YN/A
FCF growth 1Y57.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.9%
OCF growth 3YN/A
OCF growth 5YN/A

MCEWEN INC / MUX FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MUX.


What is the valuation status of MCEWEN INC (MUX) stock?

ChartMill assigns a valuation rating of 4 / 10 to MCEWEN INC (MUX). This can be considered as Fairly Valued.


What is the profitability of MUX stock?

MCEWEN INC (MUX) has a profitability rating of 2 / 10.


What is the financial health of MCEWEN INC (MUX) stock?

The financial health rating of MCEWEN INC (MUX) is 3 / 10.